Results 271 to 280 of about 61,454 (303)

Bronchodilators in the ICU

Intensive Care Medicine, 1999
Nava S, Navalesi P
openaire   +4 more sources

VIP AS A BRONCHODILATOR

The Lancet, 1984
Ralph J. Altiere, Louis Diamond
openaire   +3 more sources

The pharmacology of bronchodilators

Nurse Prescribing, 2013
This article will provide prescribers with an overview of the pharmacology of bronchodilators, which are central to the management of two major inflammatory conditions of the respiratory system: asthma and chronic obstructive pulmonary disease (COPD).
openaire   +2 more sources

Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD

COPD, 2018
S. Milne, C. Hammans, Stella Watson, C. Farah, C. Thamrin, G. King   +5 more
semanticscholar   +1 more source

Response to Bronchodilators

2002
According to the major scientific respiratory societies, the response to bronchodilator agents is assessed by using the forced expiratory volume in 1 s (FEV1) and the forced vital capacity (FVC) [1, 2]. These indexes are measured with relatively cheap instruments, such as spirometers or pneumotachographs, during a forced expiratory maneuver initiated ...
openaire   +2 more sources

Regional lung function determined by electrical impedance tomography during bronchodilator reversibility testing in patients with asthma

Physiological Measurement, 2016
I. Frerichs, Zhanqi Zhao, T. Becher, Peter Zabel, N. Weiler, B. Vogt   +5 more
semanticscholar   +1 more source

Bronchodilator testing: confidence intervals derived from placebo inhalations.

American Review of Respiratory Disease, 2015
R. L. Sourk, K. Nugent
semanticscholar   +1 more source

Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems.

American Review of Respiratory Disease, 2015
M. Tobin, G. Jenouri, I. Danta, C. Kim, H. Watson, M. Sackner   +5 more
semanticscholar   +1 more source

Exercise as a bronchodilator

Clinical Science, 1992
openaire   +3 more sources

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study.

The Lancet Respiratory Medicine, 2013
J. Wedzicha, M. Decramer, J. Ficker, D. Niewoehner, T. Sandström, A. Taylor, P. D’Andrea, Christie Arrasate, H. Chen, D. Banerji   +9 more
semanticscholar   +1 more source